Likun Chen

机构：Sun Yat-sen University, Yichun University, Sun Yat-sen University Cancer Center, Guangdong Provincial People's Hospital, State Key Laboratory of Oncology in South China · ORCID：0000-0002-7158-3878

发表论文 222 篇 · 总被引 2975 次 · h-index 28

代表论文

Phase I study of iza-bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic small cell lung cancer (SCLC). (2025 · Journal of Clinical Oncology · 被引 8)
Phase I study of iza-bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with driver genomic alterations (GA) outside of classic EGFR mutations. (2025 · Journal of Clinical Oncology · 被引 8)
Izalontamab Brengitecan in Locally Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study (2026 · Journal of Clinical Oncology · 被引 3)
High-dose furmonertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer with brain metastases after resistance to third-generation EGFR-TKIs: A retrospective study (2025 · Translational Oncology · 被引 2)
Efficacy and safety with aumolertinib plus anlotinib for untreated EGFR-mutant NSCLC with brain metastases (2025 · npj Precision Oncology · 被引 1)
First-line camrelizumab plus pemetrexed and carboplatin for advanced non-squamous non-small-cell lung cancer with brain metastases (CAP-BRAIN): final results of a multicentre, open-label, single-arm, phase 2 trial in China (2025 · EClinicalMedicine · 被引 1)